Trials / Completed
CompletedNCT01950689
NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)
A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 338 (actual)
- Sponsor
- The Christie NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to see whether adding Nimorazole to standard radiotherapy benefits patients with locally advanced head and neck squamous cell carcinoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nimorazole | |
| RADIATION | Radiotherapy |
Timeline
- Start date
- 2014-09-11
- Primary completion
- 2021-01-07
- Completion
- 2021-01-07
- First posted
- 2013-09-25
- Last updated
- 2021-10-19
Locations
21 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01950689. Inclusion in this directory is not an endorsement.